NCT02100748View on ClinicalTrials.gov

A Study of TRV130 for the Treatment of Pain After Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Acute Pain
Interventions
DRUG

TRV130

TRV130 1 - 4 mg will be administered every 4 hours

DRUG

Morphine

Morphine 4 mg will be administered every 4 hours

DRUG

Placebo

Placebo will be administered every 4 hours

Trial Locations (4)

21122

Chesapeake Research Group, Pasadena

78705

Premier Research, Austin

84124

Jean Brown Research, Salt Lake City

85027

Premier Research, Phoenix

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT02100748 - A Study of TRV130 for the Treatment of Pain After Bunionectomy | Biotech Hunter | Biotech Hunter